News from qbiotics group limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

18 Nov, 2020, 12:10 GMT QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary Medicine for the treatment...


13 Aug, 2020, 04:55 BST QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma

QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it...


28 Apr, 2020, 07:43 BST QBiotics commercialises first tigilanol tiglate pharmaceutical product with launch of STELFONTA®

Australian life sciences company, QBiotics Group Limited (QBiotics) has commercialised the first product for its lead compound, tigilanol tiglate,...


03 Dec, 2019, 06:15 GMT QBiotics Announces First Patient Dosed in its Phase I/II Clinical Trial of Tigilanol Tiglate for Head and Neck Cancer

QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, today announced that it has...